An Open-label, Fixed-Sequence Study to Investigate The Effect of Multiple Oral Doses of Pimicotinib on The Pharmacokinetics of Metformin, Fexofenadine and Rosuvastatin In Healthy Subjects
Latest Information Update: 23 Jan 2025
Price :
$35 *
At a glance
- Drugs Pimicotinib (Primary) ; Fexofenadine; Metformin; Rosuvastatin
- Indications Amyotrophic lateral sclerosis; Giant cell tumour of tendon sheath; Graft-versus-host disease; Osteosarcoma; Pancreatic cancer; Solid tumours
- Focus Pharmacokinetics
- Sponsors Abbisko Therapeutics
- 23 Jan 2025 New trial record